Vise Technologies Inc. Buys New Holdings in CVS Health Corporation $CVS

Vise Technologies Inc. purchased a new position in shares of CVS Health Corporation (NYSE:CVS) during the second quarter, Holdings Channel.com reports. The institutional investor purchased 58,892 shares of the pharmacy operator’s stock, valued at approximately $6,092,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Beaird Harris Wealth Management LLC lifted its holdings in shares of CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 195 shares during the period. J.Safra Asset Management Corp bought a new stake in CVS Health in the second quarter valued at about $30,000. Dunhill Financial LLC bought a new position in CVS Health during the second quarter worth about $32,000. Swiss RE Ltd. bought a new position in CVS Health during the fourth quarter worth about $26,000. Finally, Sankala Group LLC acquired a new stake in CVS Health during the fourth quarter valued at approximately $28,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Up 0.2%

Shares of CVS opened at $93.83 on Friday. The business’s fifty day moving average price is $102.19 and its two-hundred day moving average price is $88.83. The firm has a market capitalization of $120.01 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 0.89 and a beta of 0.61. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same quarter in the prior year, the firm posted $1.81 earnings per share. The firm’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. UBS Group boosted their price target on CVS Health from $122.00 to $126.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. HSBC reissued a “hold” rating and set a $103.00 price objective on shares of CVS Health in a report on Monday, July 6th. Bank of America boosted their target price on shares of CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Sanford C. Bernstein increased their target price on shares of CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 12th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $107.17.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.